Bin Wang, PhD
Senior Vice President, Drug Discovery
Bin joined BridgeBio Pharma in February 2020, and now leads KRAS projects as Senior Vice President of Drug Discovery for BBOT. Prior to BridgeBio, Bin was a Senior Director at Peloton Therapeutics from 2010 to 2020, as well as a Principal Scientist at Array Biopharma from 2001 to 2010.
Bin holds a PhD in Organic Chemistry from Shanghai Institute of Materia Medica, Chinese Academy of Sciences and did his postdoctoral training at Pennsylvania State University.